• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

by Fred Pennic 07/10/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

What You Should Know: 

  • Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies’ multi-year partnership and research collaboration. 
  • The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle, environment, wellness, and personal beauty routines. 

 My Skin & Hair Journey Registry 

The My Skin & Hair Journey registry includes self-identifying women aged 18-70 from various ethnicities, social backgrounds and with diverse skin and hair attributes are invited to take part by privately sharing their unique skin and hair health journeys through self-reported data and surveys. A subgroup of participants will also be invited to further testing to uncover biomarkers  — unique biological signatures – that can lead to early detection or prevention of skin disorders, before they take hold. L’Oréal will leverage insights generated from the registry to develop innovative, precision beauty offerings to support the skin and hair goals of all consumers.

“Skin health cohorts play a crucial role in unraveling the intricate connection between a wide range of biomarkers and skin health outcomes,” said Guive Balooch, L’Oréal’s Global Managing Director of Augmented Beauty and Open Innovation. “Engaging regularly over time with the study participants allows us to observe changes, pinpoint risk factors, and develop personalized skincare recommendations that enhance overall skin health and well-being. This comprehensive understanding contributes to the development of more precise and inclusive skincare approaches that cater to the diverse needs of individuals worldwide.”

The My Skin & Hair Journey longitudinal registry for skin and hair health is now enrolling participants in the United States, with the intention to expand internationally. For those interested in joining, more information can be found here.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Verily

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |